Travere Therapeutics Inc (TVTX)
5.98
+0.45
(+8.14%)
USD |
NASDAQ |
May 01, 16:00
6.08
+0.10
(+1.67%)
After-Hours: 04:51
Travere Therapeutics Cash from Financing (Quarterly): 0.124M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.124M |
| September 30, 2023 | -0.634M |
| June 30, 2023 | 2.266M |
| March 31, 2023 | 217.00M |
| December 31, 2022 | 0.551M |
| September 30, 2022 | 2.278M |
| June 30, 2022 | 0.831M |
| March 31, 2022 | 113.91M |
| December 31, 2021 | 33.21M |
| September 30, 2021 | 2.414M |
| June 30, 2021 | 0.303M |
| March 31, 2021 | 195.75M |
| December 31, 2020 | 25.04M |
| September 30, 2020 | -0.348M |
| June 30, 2020 | 108.80M |
| March 31, 2020 | -5.773M |
| December 31, 2019 | 0.095M |
| September 30, 2019 | -0.738M |
| June 30, 2019 | -0.324M |
| March 31, 2019 | -1.11M |
| December 31, 2018 | 0.525M |
| September 30, 2018 | 230.96M |
| June 30, 2018 | 3.085M |
| March 31, 2018 | -2.702M |
| December 31, 2017 | 1.361M |
| Date | Value |
|---|---|
| September 30, 2017 | 5.835M |
| June 30, 2017 | -1.897M |
| March 31, 2017 | 0.146M |
| December 31, 2016 | -5.044M |
| September 30, 2016 | 4.038M |
| June 30, 2016 | -1.917M |
| March 31, 2016 | -0.926M |
| December 31, 2015 | 1.232M |
| September 30, 2015 | -40.11M |
| June 30, 2015 | 1.106M |
| March 31, 2015 | 139.38M |
| December 31, 2014 | -0.533M |
| September 30, 2014 | 3.545M |
| June 30, 2014 | 53.69M |
| March 31, 2014 | 38.62M |
| December 31, 2013 | -0.5303M |
| September 30, 2013 | 21.13M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 8.378M |
| November 30, 2012 | |
| August 31, 2012 | |
| May 31, 2012 | |
| February 29, 2012 | |
| November 30, 2011 | |
| August 31, 2011 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-5.773M
Minimum
Mar 2020
217.00M
Maximum
Mar 2023
36.57M
Average
0.831M
Median
Jun 2022
Cash from Financing (Quarterly) Benchmarks
| AtriCure Inc | 2.359M |
| Bio-Rad Laboratories Inc | -200.62M |
| Artivion Inc | -1.63M |
| Shockwave Medical Inc | -0.164M |
| Perspective Therapeutics Inc | 0.352M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -70.47M |
| Cash from Investing (Quarterly) | -16.95M |
| Free Cash Flow | -322.28M |
| Free Cash Flow Per Share (Quarterly) | -0.9935 |
| Free Cash Flow to Equity (Quarterly) | -76.43M |
| Free Cash Flow to Firm (Quarterly) | -76.00M |
| Free Cash Flow Yield | -72.59% |